LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Spine/FDA Clears Captiva Spine’s MIS Pedicle Screw System Enhancements
Spine

FDA Clears Captiva Spine’s MIS Pedicle Screw System Enhancements

July 14, 2015 1 min read Premium comments

Advertisement

FDA Clears Captiva Spine’s MIS Pedicle Screw System Enhancements
TowerLOX MIS Pedicle Screw System / Courtesy of Captiva Spine
Secondary

Captiva Spine, Inc. which modestly describes itself in its press release as “creating and maintaining sincere, honest, collaborative relationships to deliver smart, elegant, and intuitive spinal solutions” has received 510 (k) clearance, from the FDA to market its enhanced TowerLOX MIS Pedicle Screw System.

The enhancements include what the firm calls its PivoQuik Rod-Inserter and Tower Guide to allow for rapid rod alignment and the Modular Open Tower locking mechanisms that allow for rod insertion and visualization through the central shaft of the tower.

Company President and Founder Dale Mitchell said, “We’ve obsessively invested time collaborating with leading MIS spine surgeons, discovered new resources through our vendor partners, and delivered coordinated enthusiasm through all aspects of this project.”

Minimally invasive instruments for lumbar spine surgery has become the most innovative sector in spine surgery.  Over the past four years, more MIS innovations have been submitted for the annual Orthopedics This Week Spine Technology Awards than any other category – including biologics and motion preservation implants.

Captiva Spine is a privately owned medical device organization founded in Jupiter, Florida, in 2007. For more information go to: www.captivaspine.com.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy